Multi Hanna Kreasindo Tbk. (MHKI.JK)
IDR 121.0
(6.14%)
IDR 121.0
(6.14%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Operating Cash Flow | 25.74 Billion | 47.15 Billion | 23.67 Billion | 8.17 Billion |
| Net Income | 28.7 Billion | 29.82 Billion | 9.11 Billion | 2.77 Billion |
| Depreciation & Amortization | 14 Billion | 7.38 Billion | 7.12 Billion | 5.66 Billion |
| Deferred income taxes | - | - | - | - |
| Stock-based compensation | - | - | - | - |
| Change in working capital | - | - | - | - |
| Other non-cash items | -16.96 Billion | 9.94 Billion | 7.43 Billion | -261.21 Million |
| Investing Cash Flow | -21.42 Billion | -19.98 Billion | -18.2 Billion | -10.41 Billion |
| Investments in PPE | -21.42 Billion | -20.4 Billion | -18.2 Billion | -12.15 Billion |
| Acquisitions | - | - | - | - |
| Investment purchases | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - |
| Other Investing Activities | - | 422.34 Million | 727.27 Thousand | 1.74 Billion |
| Financing Cash Flow | -696.28 Million | -19.52 Billion | 12.81 Billion | 986.53 Million |
| Debt repayment | -1.33 Billion | -531.63 Million | -37.18 Billion | -986.53 Million |
| Dividends payments | - | -20.05 Billion | - | - |
| Common Stock Repurchased | - | - | - | - |
| Common Stock Issuance | - | - | - | - |
| Other Financing Activities | -2.03 Billion | - | 50 Billion | - |
| Accounts receivables | - | - | - | - |
| Accounts payables | - | - | - | - |
| Inventory | - | - | - | - |
| Other working capital | - | - | - | - |
| Cash at beginning of period | 29.26 Billion | 21.61 Billion | 3.34 Billion | 4.59 Billion |
| Cash at end of period | 32.88 Billion | 29.26 Billion | 21.61 Billion | 3.34 Billion |
| Capital Expenditure | -21.42 Billion | -20.4 Billion | -18.2 Billion | -12.15 Billion |
| Effect of forex changes on cash | - | - | - | - |
| Net cash flow / Change in cash | 3.61 Billion | 7.65 Billion | 18.27 Billion | -1.24 Billion |
| Free Cash Flow | 4.31 Billion | 26.75 Billion | 5.46 Billion | -3.97 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 6.9 Billion | 6.9 Billion | 28.7 Billion | 5.45 Billion | 12.49 Billion | 12.49 Billion |
| Depreciation & Amortization | 2.84 Billion | 2.84 Billion | 14 Billion | 8.48 Billion | 7 Billion | 7 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | - | - |
| Other non-cash items | 5 Billion | 5 Billion | -16.96 Billion | -12.06 Billion | -16.98 Billion | -16.98 Billion |
| Investing Cash Flow | -21.43 Billion | -21.43 Billion | -21.42 Billion | -10.28 Billion | -1.26 Billion | -1.26 Billion |
| Investments in PPE | -21.72 Billion | -21.72 Billion | -21.42 Billion | -10.28 Billion | -1.62 Billion | -1.62 Billion |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 297.06 Million | 297.06 Million | - | - | 364.53 Million | 364.53 Million |
| Financing Cash Flow | 74.31 Billion | 74.31 Billion | -696.28 Million | 749.39 Million | -257.75 Million | -257.75 Million |
| Debt repayment | - | - | -1.33 Billion | -195.93 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 74.31 Billion | 74.31 Billion | -2.03 Billion | 553.46 Million | -257.75 Million | -257.75 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | - | 32.88 Billion | 29.26 Billion | 40.55 Billion | 30.26 Billion | 29.26 Billion |
| Cash at end of period | 67.64 Billion | 100.52 Billion | 32.88 Billion | 32.88 Billion | 31.25 Billion | 30.26 Billion |
| Capital Expenditure | -21.72 Billion | -21.72 Billion | -21.42 Billion | -10.28 Billion | -1.62 Billion | -1.62 Billion |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 67.64 Billion | 67.64 Billion | 3.61 Billion | -7.66 Billion | 992.07 Million | 992.07 Million |
| Free Cash Flow | -6.97 Billion | -6.97 Billion | 4.31 Billion | -8.41 Billion | 885.29 Million | 885.29 Million |
605128
0177
C6L
PPLPHARMA
ATAP
CBSM